載入...
Phase II Study of Bevacizumab and Pemetrexed for Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
OBJECTIVE: To evaluate the efficacy and safety of combination bevacizumab/pemetrexed for the treatment of recurrent epithelial ovarian cancer (EOC). METHODS: Platinum-sensitive or -resistant patients with recurrent or persistent EOC were eligible if they had received up to 2 prior chemotherapy regim...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3939037/ https://ncbi.nlm.nih.gov/pubmed/24096113 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2013.09.032 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|